[go: up one dir, main page]

DK657689D0 - Middel med biologisk virkning paa tarmslimhinden - Google Patents

Middel med biologisk virkning paa tarmslimhinden

Info

Publication number
DK657689D0
DK657689D0 DK657689A DK657689A DK657689D0 DK 657689 D0 DK657689 D0 DK 657689D0 DK 657689 A DK657689 A DK 657689A DK 657689 A DK657689 A DK 657689A DK 657689 D0 DK657689 D0 DK 657689D0
Authority
DK
Denmark
Prior art keywords
biological effect
medicine
saturated
linear
agent
Prior art date
Application number
DK657689A
Other languages
English (en)
Inventor
Sven Froekjaer
Tomas Tage Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8148900&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK657689(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK657689A priority Critical patent/DK657689D0/da
Publication of DK657689D0 publication Critical patent/DK657689D0/da
Priority to PCT/DK1990/000343 priority patent/WO1991009597A1/en
Priority to EP91901713A priority patent/EP0509009B1/en
Priority to DE69018836T priority patent/DE69018836T2/de
Priority to CA002072010A priority patent/CA2072010A1/en
Priority to DK91901713.7T priority patent/DK0509009T3/da
Priority to JP91502039A priority patent/JPH05502669A/ja
Priority to AU70466/91A priority patent/AU638541B2/en
Priority to AT91901713T priority patent/ATE121293T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK657689A 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden DK657689D0 (da)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden
PCT/DK1990/000343 WO1991009597A1 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
EP91901713A EP0509009B1 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
DE69018836T DE69018836T2 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
CA002072010A CA2072010A1 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
DK91901713.7T DK0509009T3 (da) 1989-12-22 1990-12-21 Anvendelse af et middel, hvis hovedbestanddel er et triglycerid, til fremstilling af et lægemiddel
JP91502039A JPH05502669A (ja) 1989-12-22 1990-12-21 腸粘膜に対する生物学的作用を有する薬剤として、主成分がトリグリセリドである物質の使用並びに該薬剤を含有する調製品
AU70466/91A AU638541B2 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
AT91901713T ATE121293T1 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden

Publications (1)

Publication Number Publication Date
DK657689D0 true DK657689D0 (da) 1989-12-22

Family

ID=8148900

Family Applications (2)

Application Number Title Priority Date Filing Date
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden
DK91901713.7T DK0509009T3 (da) 1989-12-22 1990-12-21 Anvendelse af et middel, hvis hovedbestanddel er et triglycerid, til fremstilling af et lægemiddel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91901713.7T DK0509009T3 (da) 1989-12-22 1990-12-21 Anvendelse af et middel, hvis hovedbestanddel er et triglycerid, til fremstilling af et lægemiddel

Country Status (8)

Country Link
EP (1) EP0509009B1 (da)
JP (1) JPH05502669A (da)
AT (1) ATE121293T1 (da)
AU (1) AU638541B2 (da)
CA (1) CA2072010A1 (da)
DE (1) DE69018836T2 (da)
DK (2) DK657689D0 (da)
WO (1) WO1991009597A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE117205T1 (de) * 1989-04-07 1995-02-15 New England Deaconess Hospital Kurzkettige triglyceride.
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
AU6539094A (en) * 1993-04-23 1994-11-21 Loders Croklaan B.V. Nutrient fats having improved digestibility
CN1104875C (zh) * 1994-03-01 2003-04-09 普罗克特和甘保尔公司 三分段式卫生巾
EP0739589B1 (en) * 1995-04-28 2001-06-13 Loders Croklaan B.V. Triglycerides, rich in Polyunsaturated fatty acids
US6410078B1 (en) 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
WO1997009978A1 (en) * 1995-09-13 1997-03-20 Morten Sloth Weidner Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
BR112021008264A2 (pt) * 2018-12-17 2021-08-03 Société des Produits Nestlé S.A. butirato dietário
ES2951327T3 (es) * 2018-12-21 2023-10-19 Nestle Sa Butirato dietético para el tratamiento o la prevención de un trastorno alérgico
CA3135099A1 (en) * 2019-05-21 2020-11-26 Societe Des Produits Nestle S.A. Dietary butyrate
CN113853120A (zh) * 2019-05-21 2021-12-28 雀巢产品有限公司 膳食丁酸酯及其用途
CN114760857A (zh) * 2019-12-05 2022-07-15 雀巢产品有限公司 膳食丁酸酯及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE407180C (de) * 1920-04-25 1924-12-09 Wilhelm Normann Dr Verfahren zur Herstellung von gemischten Glyceriden
US2879281A (en) * 1955-06-29 1959-03-24 Eastman Kodak Co Trans esterification of triglycerides by means of plural metal catalyst
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
JPS6387988A (ja) * 1986-10-01 1988-04-19 Nisshin Oil Mills Ltd:The 消化吸収性の良い油脂
FR2617161B1 (fr) * 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention

Also Published As

Publication number Publication date
ATE121293T1 (de) 1995-05-15
EP0509009B1 (en) 1995-04-19
EP0509009A1 (en) 1992-10-21
AU638541B2 (en) 1993-07-01
CA2072010A1 (en) 1991-06-23
DK0509009T3 (da) 1995-08-07
JPH05502669A (ja) 1993-05-13
DE69018836T2 (de) 1995-11-16
AU7046691A (en) 1991-07-24
WO1991009597A1 (en) 1991-07-11
DE69018836D1 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
FR2601675B1 (fr) Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
DK657689D0 (da) Middel med biologisk virkning paa tarmslimhinden
ES2149883T3 (es) Sintesis quimica de taxol y de derivados de taxol.
AR241103A1 (es) "dispositivo de rebajamiento del ala de una butaca anatomica envolvente para el vehiculo automotor o analogo, y butaca que comprende dicho dispositivo".
FI843930L (fi) Maerkta konjugat av metalltionein och maolsoekande biologiskt aktiva molekyler.
DE3869880D1 (de) Azithromycin und seine derivate als antiprotozoenmittel.
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
MA22733A1 (fr) Esters citrates acyles en tant que precurseurs de peracides.
DE69015577D1 (de) Apparatus zur Behandlung viskoser Flüssigkeiten.
ES2069843T3 (es) Utilizacion de baclofen para la obtencion de medicamentos destinados al tratamiento de la angina de pecho.
ES2051705T3 (es) Preparados con contenido de acidos grasos insaturados para la sintesis de prostaglandinas e hidroxi-acidos grasos en sistemas biologicos.
DE69004112D1 (de) Anordnung zur Hochspannungsversorgung einer Röntgenröhre.
GT196000041A (es) Antibioticos a-21978 y procedimiento para su produccion
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
ES2089157T3 (es) Nuevos derivados de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
ES2039516T3 (es) Empleo de los enantiomeros de la propafenona para la obtencion de medicamentos.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
DK92183A (da) 11beta-chlor-delta15-steroider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
SU855640A1 (ru) Стабилизированный источник посто нного напр жени
ES2051916T3 (es) Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros.
ES549671A0 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
ES1006595Y (es) Aparato para el control de tensiones psico-fisiologicas del cuerpo humano.
KR900015747A (ko) 간장관련 질병 치료제의 제조방법
ES1014237Y (es) Aparato para el control de tensiones psico-fisiologicas del cuerpo humano.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment